vs
AMN HEALTHCARE SERVICES INC（AMN）とICU MEDICAL INC（ICUI）の財務データ比較。上の社名をクリックして会社を切り替えられます
AMN HEALTHCARE SERVICES INCの直近四半期売上が大きい（$748.2M vs $540.7M、ICU MEDICAL INCの約1.4倍）。AMN HEALTHCARE SERVICES INCの純利益率が高く（-1.0% vs -2.9%、差は1.9%）。AMN HEALTHCARE SERVICES INCの前年同期比売上増加率が高い（1.8% vs -14.1%）。AMN HEALTHCARE SERVICES INCの直近四半期フリーキャッシュフローが多い（$67.6M vs $36.0M）。過去8四半期でICU MEDICAL INCの売上複合成長率が高い（-2.3% vs -4.5%）
AMNヘルスケアサービス社は米国の代表的な医療人材ソリューション企業で、病院・診療所などの医療機関に対し看護師、医師、医療技術者をはじめ臨床・非臨床スタッフの雇用紹介を行うほか、人材管理支援やコンサルティングサービスも提供している。
ICUメディカルは米国カリフォルニア州サンクレメンテに本社を置く医療技術企業で、血流感染の予防、医療従事者を感染症や危険薬剤への曝露から守るための製品を開発・提供している。製品ラインには静脈治療用品、輸液ポンプ、無針血管アクセスデバイス、カスタム輸液セット、危険薬剤密閉取扱システム、センサーカテーテル、無針密閉式採血システムなどがある。
AMN vs ICUI — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $748.2M | $540.7M |
| 純利益 | $-7.7M | $-15.7M |
| 粗利率 | 26.1% | 37.5% |
| 営業利益率 | 1.1% | 1.0% |
| 純利益率 | -1.0% | -2.9% |
| 売上前年比 | 1.8% | -14.1% |
| 純利益前年比 | 95.9% | 34.0% |
| EPS（希薄化後） | $-0.19 | $-0.63 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $748.2M | $540.7M | ||
| Q3 25 | $634.5M | $537.0M | ||
| Q2 25 | $658.2M | $548.9M | ||
| Q1 25 | $689.5M | $604.7M | ||
| Q4 24 | $734.7M | $629.8M | ||
| Q3 24 | $687.5M | $589.1M | ||
| Q2 24 | $740.7M | $596.5M | ||
| Q1 24 | $820.9M | $566.7M |
| Q4 25 | $-7.7M | $-15.7M | ||
| Q3 25 | $29.3M | $-3.4M | ||
| Q2 25 | $-116.2M | $35.3M | ||
| Q1 25 | $-1.1M | $-15.5M | ||
| Q4 24 | $-187.5M | $-23.8M | ||
| Q3 24 | $7.0M | $-33.0M | ||
| Q2 24 | $16.2M | $-21.4M | ||
| Q1 24 | $17.3M | $-39.5M |
| Q4 25 | 26.1% | 37.5% | ||
| Q3 25 | 29.1% | 37.4% | ||
| Q2 25 | 29.8% | 37.9% | ||
| Q1 25 | 28.7% | 34.7% | ||
| Q4 24 | 29.8% | 36.1% | ||
| Q3 24 | 31.0% | 34.8% | ||
| Q2 24 | 31.0% | 34.8% | ||
| Q1 24 | 31.4% | 32.7% |
| Q4 25 | 1.1% | 1.0% | ||
| Q3 25 | 7.5% | 2.6% | ||
| Q2 25 | -18.8% | 1.9% | ||
| Q1 25 | 1.8% | 2.1% | ||
| Q4 24 | -27.6% | 6.0% | ||
| Q3 24 | 3.2% | 1.4% | ||
| Q2 24 | 5.1% | 1.3% | ||
| Q1 24 | 4.9% | -1.9% |
| Q4 25 | -1.0% | -2.9% | ||
| Q3 25 | 4.6% | -0.6% | ||
| Q2 25 | -17.7% | 6.4% | ||
| Q1 25 | -0.2% | -2.6% | ||
| Q4 24 | -25.5% | -3.8% | ||
| Q3 24 | 1.0% | -5.6% | ||
| Q2 24 | 2.2% | -3.6% | ||
| Q1 24 | 2.1% | -7.0% |
| Q4 25 | $-0.19 | $-0.63 | ||
| Q3 25 | $0.76 | $-0.14 | ||
| Q2 25 | $-3.02 | $1.43 | ||
| Q1 25 | $-0.03 | $-0.63 | ||
| Q4 24 | $-4.90 | $-0.97 | ||
| Q3 24 | $0.18 | $-1.35 | ||
| Q2 24 | $0.42 | $-0.88 | ||
| Q1 24 | $0.45 | $-1.63 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $34.0M | — |
| 総負債低いほど良い | $767.1M | — |
| 株主資本純資産 | $642.1M | $2.1B |
| 総資産 | $2.1B | $4.1B |
| 負債/資本比率低いほどレバレッジが低い | 1.19× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $34.0M | — | ||
| Q3 25 | $52.6M | — | ||
| Q2 25 | $41.5M | — | ||
| Q1 25 | $55.8M | — | ||
| Q4 24 | $10.6M | $308.6M | ||
| Q3 24 | $30.6M | $312.5M | ||
| Q2 24 | $48.0M | $302.6M | ||
| Q1 24 | $50.6M | $251.4M |
| Q4 25 | $767.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $642.1M | $2.1B | ||
| Q3 25 | $644.4M | $2.1B | ||
| Q2 25 | $607.6M | $2.1B | ||
| Q1 25 | $715.1M | $2.0B | ||
| Q4 24 | $706.6M | $2.0B | ||
| Q3 24 | $890.7M | $2.0B | ||
| Q2 24 | $876.9M | $2.0B | ||
| Q1 24 | $854.2M | $2.1B |
| Q4 25 | $2.1B | $4.1B | ||
| Q3 25 | $2.1B | $4.1B | ||
| Q2 25 | $2.2B | $4.1B | ||
| Q1 25 | $2.4B | $4.2B | ||
| Q4 24 | $2.4B | $4.2B | ||
| Q3 24 | $2.7B | $4.3B | ||
| Q2 24 | $2.8B | $4.3B | ||
| Q1 24 | $2.9B | $4.3B |
| Q4 25 | 1.19× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.49× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $75.6M | $60.6M |
| フリーキャッシュフロー営業CF - 設備投資 | $67.6M | $36.0M |
| FCFマージンFCF / 売上 | 9.0% | 6.6% |
| 設備投資強度設備投資 / 売上 | 1.1% | 4.6% |
| キャッシュ転換率営業CF / 純利益 | — | — |
| 直近12ヶ月FCF直近4四半期 | $233.8M | $91.8M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $75.6M | $60.6M | ||
| Q3 25 | $22.7M | $56.7M | ||
| Q2 25 | $78.5M | $11.2M | ||
| Q1 25 | $92.7M | $51.3M | ||
| Q4 24 | $72.8M | $40.2M | ||
| Q3 24 | $66.7M | $36.1M | ||
| Q2 24 | $99.5M | $82.0M | ||
| Q1 24 | $81.4M | $45.8M |
| Q4 25 | $67.6M | $36.0M | ||
| Q3 25 | $14.8M | $27.6M | ||
| Q2 25 | $68.7M | $-8.5M | ||
| Q1 25 | $82.7M | $36.7M | ||
| Q4 24 | $56.6M | $16.1M | ||
| Q3 24 | $47.4M | $16.2M | ||
| Q2 24 | $72.2M | $62.5M | ||
| Q1 24 | $63.2M | $29.9M |
| Q4 25 | 9.0% | 6.6% | ||
| Q3 25 | 2.3% | 5.1% | ||
| Q2 25 | 10.4% | -1.5% | ||
| Q1 25 | 12.0% | 6.1% | ||
| Q4 24 | 7.7% | 2.6% | ||
| Q3 24 | 6.9% | 2.7% | ||
| Q2 24 | 9.8% | 10.5% | ||
| Q1 24 | 7.7% | 5.3% |
| Q4 25 | 1.1% | 4.6% | ||
| Q3 25 | 1.2% | 5.4% | ||
| Q2 25 | 1.5% | 3.6% | ||
| Q1 25 | 1.4% | 2.4% | ||
| Q4 24 | 2.2% | 3.8% | ||
| Q3 24 | 2.8% | 3.4% | ||
| Q2 24 | 3.7% | 3.3% | ||
| Q1 24 | 2.2% | 2.8% |
| Q4 25 | — | — | ||
| Q3 25 | 0.77× | — | ||
| Q2 25 | — | 0.32× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 9.54× | — | ||
| Q2 24 | 6.13× | — | ||
| Q1 24 | 4.70× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AMN
| Travel Nurse Staffing | $208.3M | 28% |
| Allied Staffing | $146.9M | 20% |
| Labor Disruption Services | $124.3M | 17% |
| Technology And Workforce Solutions | $88.0M | 12% |
| Language Services | $69.9M | 9% |
| Other | $29.6M | 4% |
| International Nurse Staffing | $29.6M | 4% |
| Interim Leadership Staffing | $24.1M | 3% |
| Vendor Management Systems | $16.3M | 2% |
| Local Staffing | $8.6M | 1% |
| International Nurse Permanent Placement | $2.6M | 0% |
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
